Related Experiment Video
Updated: Sep 3, 2025
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Cryptococcus neoformans Genotypic Diversity and Disease Outcome among HIV Patients in Africa
Kennedy Kassaza1, Fredrickson Wasswa1, Kirsten Nielsen2
1Department of Microbiology and Parasitology, Mbarara University of Science and Technology, Mbarara P.O. Box 1410, Uganda.
Abstract:
Cryptococcal meningoencephalitis, a disease with poor patient outcomes, remains the most prevalent invasive fungal infection worldwide, accounting for approximately 180,000 deaths each year. In several areas of sub-Saharan Africa with the highest HIV prevalence, cryptococcal meningitis is the leading cause of community-acquired meningitis, with a high mortality among HIV-infected individuals. Recent studies show that patient disease outcomes are impacted by the genetics of the infecting isolate. Yet, there is still limited knowledge of how these genotypic variations contribute to clinical disease outcome. Further, it is unclear how the genetic heterogeneity of C. neoformans and the extensive phenotypic variation observed between and within isolates affects infection and disease. In this review, we discuss current knowledge of how various genotypes impact disease progression and patient outcome in HIV-positive populations in sub-Saharan African, a setting with a high burden of cryptococcosis.
Insights
Cryptococcal meningoencephalitis causes many deaths globally, especially in HIV-positive individuals in sub-Saharan Africa. This review explores how Cryptococcus neoformans genetics influence disease outcomes in this high-burden region.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Genetics
Background:
- Cryptococcal meningoencephalitis is a leading cause of death globally, particularly among HIV-infected individuals in sub-Saharan Africa.
- It is the most common invasive fungal infection, causing around 180,000 deaths annually.
- Cryptococcal meningitis is the leading cause of community-acquired meningitis in high HIV prevalence areas of sub-Saharan Africa.
Purpose of the Study:
- To review current knowledge on the impact of Cryptococcus neoformans genotypes on disease progression and patient outcomes.
- To understand how genotypic variations and phenotypic heterogeneity of C. neoformans affect infection and disease, particularly in HIV-positive populations.
- To highlight the specific challenges and findings related to cryptococcosis in sub-Saharan Africa.
Main Methods:
- Review of existing scientific literature and recent studies.
- Analysis of research focusing on the genetics of Cryptococcus neoformans isolates.
- Examination of the correlation between genotypic variations, phenotypic differences, and clinical disease outcomes.
Main Results:
- Patient disease outcomes are significantly influenced by the genetics of the infecting Cryptococcus neoformans isolate.
- Limited knowledge exists on how specific genotypic variations contribute to clinical disease outcomes.
- The genetic heterogeneity and phenotypic variation within and between C. neoformans isolates impact infection and disease severity.
Conclusions:
- Understanding the genetic basis of C. neoformans is crucial for improving patient outcomes in cryptococcal meningoencephalitis.
- Further research is needed to elucidate the precise mechanisms by which C. neoformans genotypes affect disease progression.
- Targeted strategies considering isolate genetics may improve treatment and management of cryptococcosis in high-burden regions like sub-Saharan Africa.
